Skip to Main Content

Paper Details

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Mol Cancer Ther
20
2015
AOCS, ATP13A4, BMP8B, CACNA1C, CCNE1, Cancer, DYRK1B, GAB2, HGSC, High-Grade Serous Ovarian Cancer, Ovarian Cancer, Ovarian Tumor, PAK4, PF-04691502, PI3K, RAD21, TPX2, URI, ZFP36, copy number amplified genes, high-grade serous ovarian carcinoma, mTOR, ovarian carcinoma, patient, patients, tumor
Author NameAffiliation
Sally J DavisPeter MacCallum Cancer Centre, The University of Melbourne
Susan R DavisPeter MacCallum Cancer Centre, The University of Melbourne
Karen E SheppardPeter MacCallum Cancer Centre, The University of Melbourne
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioUniversity of British Columbia
Joshy GeorgePeter MacCallum Cancer Centre
Joshy GeorgePeter MacCallum Cancer Centre
Nadia TraficantePeter MacCallum Cancer Centre
Nadia TraficantePeter MacCallum Cancer Centre
Sian FeredayPeter MacCallum Cancer Centre
Sian FeredayPeter MacCallum Cancer Centre
Maria P IntermaggioKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
Maria P IntermaggioKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
Usha MenonGynaecological Cancer Research Centre, University College London, Institute for Women's Health
Usha MenonGynaecological Cancer Research Centre, University College London, Institute for Women's Health
Aleksandra Gentry-MaharajGynaecological Cancer Research Centre, University College London, Institute for Women's Health
Aleksandra Gentry-MaharajGynaecological Cancer Research Centre, University College London, Institute for Women's Health
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jacek GronwaldInternational Hereditary Cancer Center, Pomeranian Medical University
Jacek GronwaldInternational Hereditary Cancer Center, Pomeranian Medical University
Celeste Leigh PearceUniversity of Michigan ann arbor
Celeste Leigh PearceUniversity of Michigan ann arbor
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Malcolm C PikeMemorial Sloan-Kettering Cancer Center
Anna H WuKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
Anna H WuKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
Stefan KommossTuebingen University
Stefan KommossTuebingen University
Jacobus PfistererKiel University
Andreas du Bois
Felix HilpertUniversity Hospital Schleswig-Holstein
Susan J RamusKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
Susan J RamusKeck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellPeter MacCallum Cancer Centre
David G HuntsmanUniversity of British Columbia
David G HuntsmanUniversity of British Columbia
Richard B PearsonPeter MacCallum Cancer Centre, The University of Melbourne
Kaylene J SimpsonThe University of Melbourne, Peter MacCallum Cancer Centre
Kaylene J SimpsonThe University of Melbourne, Peter MacCallum Cancer Centre
Ian G CampbellPeter MacCallum Cancer Centre, The University of Melbourne
Kylie L GorringePeter MacCallum Cancer Centre, The University of Melbourne
  • 1 - 43

Datasets